These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15506654)

  • 21. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study.
    López-Siguero J; Borrás Pérez MV; Balser S; Khan-Boluki J
    Adv Ther; 2011 Oct; 28(10):879-93. PubMed ID: 21948492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
    Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
    Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
    Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
    J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
    Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
    Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study.
    Nunez SB; Municchi G; Barnes KM; Rose SR
    J Clin Endocrinol Metab; 1996 May; 81(5):1927-32. PubMed ID: 8626859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children].
    Codner E; Méricq V; Ugarte F; Iñíguez G; Espinoza M; Avila A; Salazar T; Cassorla F; García H
    Rev Med Chil; 1999 Jul; 127(7):807-13. PubMed ID: 10668288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
    Tonella P; Flück CE; Mullis PE
    Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of bone turnover in children with GH deficiency treated with GH until final height.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Cupelli D; Saggese G
    Eur J Endocrinol; 2000 Jun; 142(6):549-56. PubMed ID: 10822216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.